Brentuximab vedotin as a bridge to allogeneic stem-cell transplantation for refractory or relapsing patients with CD30 positive anaplastic or T-cell non-Hodgkin lymphomas: a study on behalf of the SFGM-TC. Issue 11 (19th September 2019) - Garciaz, Sylvain; Loschi, Mickael; De Masson, Adèle; Biard, Lucie; Mercier, Mélanie; Tomowiak, Cécile; Delage, Jeremy; Labussiere-Wallet, Hélène; Sibon, David; Cassuto, Ophélie; Borel, Cécile; Cornillon, Jérome; et al.